- Piperidinyl pyrrolidinyl methanone compounds as renin inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases associated with aspartic protease activity, World Intellectual Property Organization, , ,
Cas no 96567-93-0 (1-Benzyl-3-methylpyrrolidin-3-ol)
96567-93-0 structure
Product Name:1-Benzyl-3-methylpyrrolidin-3-ol
CAS No:96567-93-0
MF:C12H17NO
MW:191.269483327866
MDL:MFCD11100985
CID:797012
PubChem ID:18629648
Update Time:2024-10-25
1-Benzyl-3-methylpyrrolidin-3-ol Chemical and Physical Properties
Names and Identifiers
-
- 1-Benzyl-3-methylpyrrolidin-3-ol
- 1-Benyl-3-methylpyrrolidin-3-ol
- 3-Pyrrolidinol, 3-methyl-1-(phenylmethyl)-
- 3-Methyl-1-(phenylmethyl)-3-pyrrolidinol (ACI)
- 1-Benzyl-3-hydroxy-3-methylpyrrolidine
- racemic 3-methyl-1-(phenylmethyl)-3-pyrrolidinol
- CS-0055108
- AKOS006306890
- EN300-98665
- SSWHTEXLCLEUBQ-UHFFFAOYSA-N
- DB-013790
- (+/-)1-benzyl-3-methylpyrrolidin-3-ol
- 1-benzyl-3-methyl-pyrrolidin-3-ol
- AB92133
- SY097841
- Benzyl-3-methyl-pyrrolidin-3-ol
- DTXSID70595291
- 1-Benzyl-3-Methylpyrrolidine-3-ol
- MFCD11100985
- WDA56793
- SCHEMBL951796
- 96567-93-0
-
- MDL: MFCD11100985
- Inchi: 1S/C12H17NO/c1-12(14)7-8-13(10-12)9-11-5-3-2-4-6-11/h2-6,14H,7-10H2,1H3
- InChI Key: SSWHTEXLCLEUBQ-UHFFFAOYSA-N
- SMILES: OC1(CCN(CC2C=CC=CC=2)C1)C
Computed Properties
- Exact Mass: 191.13100
- Monoisotopic Mass: 191.131014166g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 189
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 23.5?2
Experimental Properties
- PSA: 23.47000
- LogP: 1.58120
1-Benzyl-3-methylpyrrolidin-3-ol Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-Benzyl-3-methylpyrrolidin-3-ol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A109005141-1g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 95% | 1g |
$336.96 | 2023-08-31 | |
| Alichem | A109005141-5g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 95% | 5g |
$896.88 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | P178577-1g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 97% | 1g |
¥362.90 | 2023-09-01 | |
| Chemenu | CM198061-5g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 95% | 5g |
$830 | 2021-08-05 | |
| TRC | B535293-50mg |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 50mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B535293-100mg |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 100mg |
$ 65.00 | 2022-06-07 | ||
| TRC | B535293-500mg |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 500mg |
$ 80.00 | 2022-06-07 | ||
| Fluorochem | 220935-10g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 95% | 10g |
£236.00 | 2022-03-01 | |
| Fluorochem | 220935-25g |
1-Benzyl-3-methylpyrrolidin-3-ol |
96567-93-0 | 95% | 25g |
£405.00 | 2022-03-01 | |
| abcr | AB460992-100g |
1-Benzyl-3-methylpyrrolidin-3-ol, 95%; . |
96567-93-0 | 95% | 100g |
€1336.70 | 2025-04-14 |
1-Benzyl-3-methylpyrrolidin-3-ol Production Method
Production Method 1
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; rt → -70 °C; 2 min, -70 °C; -70 °C → rt; overnight, rt
1.2 Reagents: Ammonium chloride Solvents: Water
1.2 Reagents: Ammonium chloride Solvents: Water
Reference
Production Method 2
Reaction Conditions
1.1 Solvents: Tetrahydrofuran ; -20 °C; -20 °C → rt
1.2 Reagents: Water
1.2 Reagents: Water
Reference
- Triazolopyridine compounds as PIM kinase inhibitors and their preparation, World Intellectual Property Organization, , ,
Production Method 3
Reaction Conditions
1.1 Solvents: Tetrahydrofuran ; 0 °C
Reference
- Pharmacophore modal-based design and synthesis of new structure small molecule CCR2 inhibitorsQin, Lihuai; Li, Xiaoguang; Wang, Zhilong; Yao, Wenbo; Wang, Hui; et al, Huaxue Xuebao, 2015, 73(7), 679-684
Production Method 4
Reaction Conditions
Reference
- Preparation of substituted pyrazole derivatives for use as CCR-2 and CCR-5 receptor antagonists, World Intellectual Property Organization, , ,
Production Method 5
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; 3 h, -20 °C; -20 °C → 0 °C
Reference
- Preparation of 1-(hetero)aryl-3-amino-pyrrolidine derivatives as mGluR3 receptor antagonists, World Intellectual Property Organization, , ,
Production Method 6
Reaction Conditions
Reference
- On the Ritter reaction of cyclic hydroxyamines: synthesis of conformationally-restricted reduced amide dipeptide isosteresTaylor, G. Mark; Baker, Stewart J.; Gedney, Andrea; Pearson, David J.; Sibley, Graham E. M., Tetrahedron Letters, 1996, 37(8), 1297-300
Production Method 7
Reaction Conditions
Reference
- 1,8-Naphthyridine derivatives, European Patent Organization, , ,
Production Method 8
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; rt → -70 °C; 2 min, -70 °C; overnight, rt
1.2 Reagents: Ammonium chloride Solvents: Water
1.2 Reagents: Ammonium chloride Solvents: Water
Reference
- Acylpiperidine compounds as renin inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases associated with aspartic protease activity, World Intellectual Property Organization, , ,
Production Method 9
Reaction Conditions
1.1 Solvents: Tetrahydrofuran ; 3 h, -20 °C
Reference
- 1,4-Dihydropyridine-3,5-dicarboxylate derivatives as calcium channel blockers and their preparation, pharmaceutical compositions and use in the treatment of diseases, World Intellectual Property Organization, , ,
Production Method 10
Reaction Conditions
1.1 Solvents: Tetrahydrofuran ; 0 °C; 1 h, 0 °C
1.2 Reagents: Ammonium chloride Solvents: Water
1.2 Reagents: Ammonium chloride Solvents: Water
Reference
- Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)Huard, Kim ; Ahn, Kay; Amor, Paul; Beebe, David A.; Borzilleri, Kris A.; et al, Journal of Medicinal Chemistry, 2017, 60(18), 7835-7849
Production Method 11
Reaction Conditions
1.1 Solvents: Diethyl ether , Toluene , Tetrahydrofuran ; 1.5 h, 0 °C
1.2 Reagents: Water
1.2 Reagents: Water
Reference
- [(Pyrimidinylhydrazino)-3-oxopropyl]hydroxyformamide derivatives as bacterial peptide deformylase inhibitors and preparation, pharmaceutical compositions and use in the treatment of bacterial infections, World Intellectual Property Organization, , ,
Production Method 12
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; 0 °C; 40 min, 0 °C
1.2 Reagents: Ammonium chloride Solvents: Water
1.2 Reagents: Ammonium chloride Solvents: Water
Reference
- Aminopyrimidine derivatives as kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer, World Intellectual Property Organization, , ,
Production Method 13
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; rt → -70 °C; 5 min, -70 °C; -70 °C → rt; overnight, rt
1.2 Reagents: Ammonium chloride Solvents: Water
1.2 Reagents: Ammonium chloride Solvents: Water
Reference
- Preparation of adamantylpyrrolidinecarboxylate derivatives and analogs for use as 11-beta-hydroxysteroid dehydrogenase 1 inhibitors, World Intellectual Property Organization, , ,
Production Method 14
Reaction Conditions
1.1 Solvents: Diethyl ether , Tetrahydrofuran ; 0 °C; 1 h, 0 °C
1.2 Reagents: Water Solvents: Diethyl ether
1.2 Reagents: Water Solvents: Diethyl ether
Reference
- Preparation of quinolinecarboxyamide derivatives for use in the treatment of inflammatory diseases, World Intellectual Property Organization, , ,
1-Benzyl-3-methylpyrrolidin-3-ol Raw materials
1-Benzyl-3-methylpyrrolidin-3-ol Preparation Products
1-Benzyl-3-methylpyrrolidin-3-ol Suppliers
Amadis Chemical Company Limited
Gold Member
(CAS:96567-93-0)1-Benzyl-3-methylpyrrolidin-3-ol
Order Number:A845612
Stock Status:in Stock
Quantity:100g
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 07:06
Price ($):669.0
Email:[email protected]
1-Benzyl-3-methylpyrrolidin-3-ol Related Literature
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
96567-93-0 (1-Benzyl-3-methylpyrrolidin-3-ol) Related Products
- 144043-26-5(3-Pyrrolidinol, 4,4-dimethyl-1-(phenylmethyl)-, (3S)-)
- 137172-64-6((3R,4S)-1-benzyl-4-methylpyrrolidin-3-ol)
- 620536-51-8(3-Pyrrolidinol,3-ethyl-4-methyl-1-(phenylmethyl)-,(3R,4S)-rel-(9CI))
- 637038-98-3(3-Pyrrolidinol, 3-[[(2-hydroxyethyl)amino]methyl]-1-(phenylmethyl)-)
- 143728-93-2(trans-1-Benzyl-4-methyl-pyrrolidin-3-ol)
- 125033-36-5(3-(Aminomethyl)-1-benzylpyrrolidin-3-ol)
- 151096-94-5(4-PIPERIDINOL, 1-(PHENYLMETHYL)-4-[[(PHENYLMETHYL)AMINO]METHYL]-)
- 1393732-45-0(1-Benzyl-3-(hydroxymethyl)pyrrolidin-3-ol)
- 144124-87-8(3-Pyrrolidinol, 4-methyl-1-(phenylmethyl)-, trans-(±)-)
- 137172-65-7((3S,4R)-1-benzyl-4-methylpyrrolidin-3-ol)
Recommended suppliers
Amadis Chemical Company Limited
(CAS:96567-93-0)1-Benzyl-3-methylpyrrolidin-3-ol
Purity:99%
Quantity:100g
Price ($):669.0